Willems L - Search Results

1

Therapeutic drug monitoring of phenytoin in critically ill patients.

von Winckelmann SL, Spriet I, Willems L. von Winckelmann SL, et al. Among authors: willems l. Pharmacotherapy. 2008 Nov;28(11):1391-400. doi: 10.1592/phco.28.11.1391. Pharmacotherapy. 2008. PMID: 18956999 Review.

2

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.

Spriet I, Annaert P, Meersseman P, Hermans G, Meersseman W, Verbesselt R, Willems L. Spriet I, et al. Among authors: willems l. J Antimicrob Chemother. 2009 Apr;63(4):767-70. doi: 10.1093/jac/dkp026. Epub 2009 Feb 13. J Antimicrob Chemother. 2009. PMID: 19218271

3

Augmented renal clearance in the critically ill: how to assess kidney function.

Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I. Grootaert V, et al. Among authors: willems l. Ann Pharmacother. 2012 Jul-Aug;46(7-8):952-9. doi: 10.1345/aph.1Q708. Epub 2012 Jun 12. Ann Pharmacother. 2012. PMID: 22693271

4

Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.

Spriet I, Brüggemann RJ, Annaert P, Meersseman P, Van Wijngaerden E, Lagrou K, Willems L. Spriet I, et al. Among authors: willems l. Ther Drug Monit. 2013 Feb;35(1):141-3. doi: 10.1097/FTD.0b013e31827d76b0. Ther Drug Monit. 2013. PMID: 23296095

5

Appropriateness of Acid Suppression Therapy.

De Rijdt T, Spriet I, Willems L, Blanckaert M, Hiele M, Wilmer A, Simoens S. De Rijdt T, et al. Among authors: willems l. Ann Pharmacother. 2017 Feb;51(2):125-134. doi: 10.1177/1060028016670414. Epub 2016 Oct 1. Ann Pharmacother. 2017. PMID: 27650819

6

Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus.

Spriet I, Meersseman W, De Troy E, Wilmer A, Casteels M, Willems L. Spriet I, et al. Among authors: willems l. Am J Health Syst Pharm. 2007 Jan 1;64(1):54-8. doi: 10.2146/ajhp050512. Am J Health Syst Pharm. 2007. PMID: 17189580

7

Interaction between valproate and meropenem: a retrospective study.

Spriet I, Goyens J, Meersseman W, Wilmer A, Willems L, Van Paesschen W. Spriet I, et al. Among authors: willems l. Ann Pharmacother. 2007 Jul;41(7):1130-6. doi: 10.1345/aph.1K079. Epub 2007 Jul 3. Ann Pharmacother. 2007. PMID: 17609232

8

Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU.

Spriet I, Meersseman W, de Hoon J, von Winckelmann S, Wilmer A, Willems L. Spriet I, et al. Among authors: willems l. Intensive Care Med. 2009 Apr;35(4):603-12. doi: 10.1007/s00134-008-1383-2. Epub 2009 Jan 9. Intensive Care Med. 2009. PMID: 19132344 Review.

9

Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis.

Spriet I, Meersseman W, Annaert P, de Hoon J, Willems L. Spriet I, et al. Among authors: willems l. Eur J Clin Pharmacol. 2011 Jul;67(7):753-5. doi: 10.1007/s00228-011-1066-8. Epub 2011 Jun 3. Eur J Clin Pharmacol. 2011. PMID: 21638033 No abstract available.

10

No interaction between valproate and meropenem in a cirrhotic patient.

Spriet I, Willems L. Spriet I, et al. Among authors: willems l. Ann Pharmacother. 2011 Sep;45(9):1167-8. doi: 10.1345/aph.1Q165. Epub 2011 Aug 2. Ann Pharmacother. 2011. PMID: 21811003 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters